BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
ClearPoint Neuro
CLPT
$386M
| $21.9M | ﹤0.01% |
1,149,210
+829,123
| +259% | +$16M |
|
3227
Rekor Systems
REKR
$94.9M
| $21.9M | ﹤0.01% |
2,158,632
+1,439,756
| +200% | +$22.1M |
|
3228
GCM Grosvenor
GCMG
$816M
| $21.9M | ﹤0.01% |
2,104,183
+1,908,108
| +973% | +$22.5M |
|
3229
GT Biopharma
GTBP
$11.8M
| $21.9M | ﹤0.01% |
+47,113
| New | +$19.6M |
|
|
STXB
3230
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $21.9M | ﹤0.01% |
958,258
-99,186
| -9% | -$2.29M |
|
|
LOGC
3231
DELISTED
ContextLogic
LOGC
| $21.9M | ﹤0.01% |
55,358
-75,157
| -58% | -$26.6M |
|
|
EMKR
3232
DELISTED
Emcore Corp
EMKR
| $21.9M | ﹤0.01% |
237,195
+170,414
| +255% | +$13.8M |
|
3233
First Bancorp
FNLC
$402M
| $21.9M | ﹤0.01% |
742,452
-87,613
| -11% | -$2.62M |
|
3234
Cogent Biosciences
COGT
$7.32B
| $21.7M | ﹤0.01% |
2,677,388
+2,109,352
| +371% | +$17.8M |
|
3235
Spyre Therapeutics
SYRE
$9.11B
| $21.6M | ﹤0.01% |
124,155
-9,857
| -7% | -$1.79M |
|
|
TEF
3236
DELISTED
Telefonica
TEF
| $21.6M | ﹤0.01% |
4,920,052
+438,514
| +10% | +$1.9M |
|
|
DZSI
3237
DELISTED
DZS Inc. Common Stock
DZSI
| $21.6M | ﹤0.01% |
1,038,764
+113,372
| +12% | +$1.97M |
|
3238
PUT
Uber
UBER
$147B
| $21.5M | ﹤0.01% |
+428,300
| New | +$22.4M |
|
3239
NN Inc
NNBR
$297M
| $21.5M | ﹤0.01% |
2,920,655
-163,721
| -5% | -$1.23M |
|
|
YELL
3240
DELISTED
Yellow Corporation Common Stock
YELL
| $21.5M | ﹤0.01% |
3,296,911
+2,262,353
| +219% | +$16.8M |
|
3241
BCE
BCE
$20.5B
| $21.4M | ﹤0.01% |
434,889
+36,024
| +9% | +$1.74M |
|
3242
Treace Medical Concepts
TMCI
$307M
| $21.3M | ﹤0.01% |
+682,341
| New | +$21.7M |
|
3243
Lexicon Pharmaceuticals
LXRX
$1.11B
| $21.3M | ﹤0.01% |
4,646,859
+742,712
| +19% | +$3.58M |
|
3244
Harmony Gold Mining
HMY
$10.5B
| $21.3M | ﹤0.01% |
5,697,932
+297,907
| +6% | +$1.41M |
|
|
SHYM
3245
iShares Short Duration High Yield Muni Active ETF
SHYM
$800M
| $21.2M | ﹤0.01% |
800,000
| – | – |
|
3246
VanEck Semiconductor ETF
SMH
$72.3B
| $21.2M | ﹤0.01% |
161,670
+85,012
| +111% | +$10.5M |
|
3247
VirnetX Holding Corp
VHC
$56.8M
| $21.2M | ﹤0.01% |
247,985
-5,093
| -2% | -$478K |
|
|
TACO
3248
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $21.2M | ﹤0.01% |
2,114,690
-193,808
| -8% | -$2.03M |
|
|
EIGR
3249
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $21.1M | ﹤0.01% |
82,537
-1,161
| -1% | -$290K |
|
3250
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $21.1M | ﹤0.01% |
42,904
-16,493
| -28% | -$8.14M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.